ASH25 - clonoSEQ

Exquisitely sensitive, highly specific, tumor informed

Medicare covered, no restriction on number of tests
FDA-cleared, CLIA validated

Join us for our 2025 ASH Corporate Reception

To learn more about how Adaptive is advancing disease assessment for lymphoid cancers

Icebar
Orlando
December 6, 2025
8:30-11:30pm

Join us for Adaptive’s 5th Annual Program Promoting Equity in Hematology

Adaptive Biotechnologies would like to personally invite you to an evening of networking

Rosen Plaza Hotel
Orlando
December 6, 2025
7:30-9:00pm

Learn more about clonoSEQ:

clonoSEQ is covered by Medicare and >90% of patients pay $0 out of pocket. Learn more about our patient support program:

Online access to your clonoSEQ results:

Take your EMR from integrated to optimized.
Learn more about EMR integration with clonoSEQ:

Meet us at booth 1701 or request information from a member of our Medical Affairs team.